Correlation Between Akanda Corp and Sunshine Biopharma
Can any of the company-specific risk be diversified away by investing in both Akanda Corp and Sunshine Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akanda Corp and Sunshine Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akanda Corp and Sunshine Biopharma Warrant, you can compare the effects of market volatilities on Akanda Corp and Sunshine Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akanda Corp with a short position of Sunshine Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akanda Corp and Sunshine Biopharma.
Diversification Opportunities for Akanda Corp and Sunshine Biopharma
-0.41 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Akanda and Sunshine is -0.41. Overlapping area represents the amount of risk that can be diversified away by holding Akanda Corp and Sunshine Biopharma Warrant in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sunshine Biopharma and Akanda Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akanda Corp are associated (or correlated) with Sunshine Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sunshine Biopharma has no effect on the direction of Akanda Corp i.e., Akanda Corp and Sunshine Biopharma go up and down completely randomly.
Pair Corralation between Akanda Corp and Sunshine Biopharma
Given the investment horizon of 90 days Akanda Corp is expected to under-perform the Sunshine Biopharma. But the stock apears to be less risky and, when comparing its historical volatility, Akanda Corp is 8.04 times less risky than Sunshine Biopharma. The stock trades about -0.05 of its potential returns per unit of risk. The Sunshine Biopharma Warrant is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 36.00 in Sunshine Biopharma Warrant on August 28, 2024 and sell it today you would lose (14.00) from holding Sunshine Biopharma Warrant or give up 38.89% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 76.89% |
| Values | Daily Returns |
Akanda Corp vs. Sunshine Biopharma Warrant
Performance |
| Timeline |
| Akanda Corp |
| Sunshine Biopharma |
Akanda Corp and Sunshine Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akanda Corp and Sunshine Biopharma
The main advantage of trading using opposite Akanda Corp and Sunshine Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akanda Corp position performs unexpectedly, Sunshine Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sunshine Biopharma will offset losses from the drop in Sunshine Biopharma's long position.| Akanda Corp vs. China SXT Pharmaceuticals | Akanda Corp vs. Petros Pharmaceuticals | Akanda Corp vs. GelStat Corp | Akanda Corp vs. Shuttle Pharmaceuticals |
| Sunshine Biopharma vs. Sunshine Biopharma | Sunshine Biopharma vs. Thayer Ventures Acquisition | Sunshine Biopharma vs. Biofrontera Warrants | Sunshine Biopharma vs. Neurosense Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |